← Leaderboards
Kenneth Alibek
Afg Biosolutions, Inc.
$1,361,758
Attributed
$1,361,758
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $432.8K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$1,361,758 · 3
By mechanism
R43$1,361,758 · 3
Top collaborators
No co-investigators on record.
Most similar at Afg Biosolutions, Inc.
Same institution · by research overlap
- Vladimir A Karginov$4,904,051
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionPreventEmergency Service/First ResponderHospitalsNisinPeptidesCessation Of LifeDoseFood PreservativesGerminationLungBacillus Anthracis SporeBacterial InfectionsBaseBinding (Molecular Function)AntibioticsAnimalsDesignAntibiotic TherapyEventAnthrax DiseaseFormulations, DrugBacillus AnthracisProtocols, Treatment
Grant awards (4)
Inhaled nisin as an emergency intervention against antibiotic sensitive or resist$299,798
R43 · FY2008 · AI · contact PI
Nisin as a decontaminant for B. anthracis spores on human skin$311,603
R43 · FY2007 · AI · contact PI
Nisin as a decontaminant for B. anthracis spores on human skin$317,528
R43 · FY2006 · AI · contact PI
New Generation of Anthrax Prophylaxis and Therapy$432,829
R43 · FY2005 · AI